PROOF OF CONCEPT STUDY ON THE EFFICACY OF INHALATORY TARGETED IMATINIB NANOFORMULATIONS IN PULMONARY HYPERTENSION AND POST-INFLAMMATORY FIBROSIS.

Clinical trial NCT06917196 · RECRUITING

Trial details

NCT number: NCT06917196
Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia
Status: RECRUITING
Study type: OBSERVATIONAL

Pulmonary Arterial Hypertension (PAH)Lung Fibrosis Interstitial

Start date: 2023-12-04
Primary completion: 2025-12-04
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.